FDA Adverse Event Injury Summary report: N

TANDEM T:SLIM INSULIN DELIVERY SYSTEM

MDR report key: 7310394 · Received March 2, 2018

Report

Report Number
3013756811-2018-06075
Event Type
Injury
Date Received
March 2, 2018
Date of Event
February 7, 2018
Report Date
March 2, 2018
Manufacturer
TANDEM DIABETES CARE
Product Code
LZG
PMA / PMN Number
K111210
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HAS BEEN RECEIVED FOR EVALUATION; HOWEVER, DEVICE EVALUATION IS NOT YET COMPLETE. A SUPPLEMENTAL REPORT WILL BE FILED UPON COMPLETION OF THE EVALUATION.

Additional Manufacturer Narrative · 1

THE INVESTIGATION HAS BEEN COMPLETED. BASED ON THE ANALYSIS, THE ALLEGED MALFUNCTION COULD NOT BE VERIFIED; HOWEVER, A DIFFERENT ISSUE WAS IDENTIFIED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PUMP DATA WAS INACCURATE. REPORTEDLY, ON MULTIPLE OCCASIONS, THE CUSTOMER DELIVERED BOLUS DOSINGS AROUND 7 AM, AND PUMP HISTORY DISPLAYED THAT THE BOLUS REQUESTS HAD BEEN DELIVERED AT 9:09 AM AND 10:13 AM. REVIEW OF THE PUMP DATA LOGS BY TANDEM TECHNICAL SUPPORT VERIFIED THAT THE BOLUS DOSAGES HAD BEEN PROGRAMMED AND DELIVERED AT 9:09 AM AND 10:13 AM; HOWEVER, THE CUSTOMER MAINTAINED THAT THE DATA WAS INACCURATE. BLOOD GLUCOSE (BG) LEVEL RANGED FROM 200-530 (MG/DL); HOWEVER, THE CUSTOMER WAS UNABLE TO CONFIRM IF THE REPORTED ISSUE WAS THE SUSPECTED CAUSE OF THE ELEVATED BG LEVEL. A CORRECTION BOLUS WAS DELIVERED AND THE INFUSION SET WAS CHANGED TO ADDRESS BG LEVEL. REPORTEDLY, THE CUSTOMER CONTINUED USING THE PUMP FOR INSULIN THERAPY, AND IN ADDITION, HAD MANUAL INJECTIONS AVAILABLE AS ALTERNATE INSULIN THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
153974 TANDEM T:SLIM INSULIN DELIVERY SYSTEM INSULIN PUMP LZG TANDEM DIABETES CARE 004628

Patients

Seq Age Sex Outcome Treatment
1 14 YR Other INSULIN: NOVOLOG, INFUSION SET: CLEO